SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.

Otros idiomas Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Acciones

002399

CNE100000P02

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 15/07/2024			Varia. Cinco días.	Varia. 1 de enero.
9,68 ^CNY	+10,00 %		+16,21 %	-17,48 %

12/07	El beneficio de Shenzhen Hepalink Pharmaceutical se disparará casi un 500% en el primer semestre	MT
12/07	Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Proporciona una orientación de ganancias consolidadas para los seis meses que finalizan el 30 de junio de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Shenzhen Hepalink Pharmaceutical's Profit to Soar Nearly 500% in H1	12/07
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2024	12/07
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Shenzhen Hepalink Receives Thai Approval for Blood Clot Drug Exarane	02/04
Thailand Food and Drug Administration Approves for Sales in the Market of Exarane Produced by Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s Wholly-Owned Subsidiary Shenzhen Techdow Medicine Co., Ltd	02/04
Shenzhen Hepalink Pharmaceutical Widens 2023 Loss as Revenue Drops 24%	01/04
Shenzhen Techdow Medicine Co., Ltd., Wholly-Owned Subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Exarane Obtains Approval from New Zealand Medicines and Medical Devices Safety Authority	28/03
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces No Final Dividend for the Year Ended 31 December 2023	28/03
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(SEHK:9989) dropped from FTSE All-World Index	18/03
Hepalink Pharmaceutical Gets Lifeline from Controlling Shareholder	15/03
Shenzhen Hepalink Forecasts Loss in 2023; Shares Slide 4%	31/01
Shenzhen Hepalink Flags Provisions of Up to 950 Million Yuan; Shares Fall 4%	31/01
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Provides Earnings Guidance for the Period from January 1, 2023 to December 31, 2023	30/01
Hepalink Faces Regulatory Scrutiny After 12 Million Euro Telecom Fraud; Hong Kong Shares Down 3%	16/01
Hepalink Pharma Unit Hit by 11.7 Million Euro Telecom Fraud	15/01
Hepalink Pharma Associate HighTide Therapeutics to Debut in Hong Kong on Friday	18/12
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(SZSE:002399) dropped from Shenzhen Stock Exchange Component Index	11/12
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(SZSE:002399) dropped from Shenzhen Stock Exchange Component A Share Index	11/12
Hepalink Pharmaceutical's Profit Drops 86% in Q3; Shares Slump 4%	31/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Acciones

002399

CNE100000P02

Otros idiomas

Filtros